Literature DB >> 9182248

Reserpine-induced immunocytochemical change of neuropeptide Y in the hypothalamic arcuate nucleus.

H Okamura1, T Sugano, Y Ibata.   

Abstract

The effect of reserpine on neuropeptide Y immunoreactive (NPY-IR) neurons in the rat hypothalamic arcuate nucleus was examined by immunocytochemical techniques. Although only NPY-IR fibers and terminals were distributed in this nucleus in untreated and saline treated rats, single treatment of reserpine (10 mg/kg, i.p.) visualized abundant NPY-IR neuronal cell bodies: the increase began at 12 h of postinjection, reached its maximal level at 48 h, and returned to its normal level at 96 h. Pretreatment of nialamide, a monoamine oxidase inhibitor, prevented these acute reserpine-induced changes, suggesting reserpine acts on NPY neurons through monoaminergic mechanism. Chronic treatment of haloperidol (5 mg/kg, once daily for 5 days) a dopamine receptor antagonist, could induce the similar increase of NPY immunoreactivity. However, interruption of adrenergic and serotonergic neurotransmissions by chronic treatment of propranorol and methysergide, or chemical lesions of ascending noradrenergic and serotonergic pathways by 6-hydroxydopamine and 5,6-dihydroxytryptamine, could not induce any immunoreactive increase of NPY in arcuate neurons. These findings strongly suggest that reserpine-induced NPY increase occurs through dopaminergic afferents in hypothalamic arcuate neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9182248     DOI: 10.1007/BF02529140

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  23 in total

1.  Influence of reserpine administration on neuropeptide Y immunoreactivity in the locus coeruleus and caudate-putamen nucleus of the rat brain.

Authors:  M Smiałowska; B Legutko
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Inhibition of hypothalamic neuropeptide Y gene expression by insulin.

Authors:  M W Schwartz; A J Sipols; J L Marks; G Sanacora; J D White; A Scheurink; S E Kahn; D G Baskin; S C Woods; D P Figlewicz
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

Review 3.  The dorsomedial hypothalamic nucleus revisited: 1986 update.

Authors:  L L Bernardis; L L Bellinger
Journal:  Brain Res       Date:  1987-07       Impact factor: 3.252

4.  An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat.

Authors:  F L Bai; M Yamano; Y Shiotani; P C Emson; A D Smith; J F Powell; M Tohyama
Journal:  Brain Res       Date:  1985-04-01       Impact factor: 3.252

5.  Effect of haloperidol on immunoreactive neuropeptide Y in rat cerebral cortex and basal ganglia.

Authors:  M Miyake; K Iguchi; H Okamura; K Fukui; T Nakajima; K Chihara; Y Ibata; N Yanaihara
Journal:  Brain Res Bull       Date:  1990-08       Impact factor: 4.077

6.  Haloperidol-induced increase in neuropeptide Y immunoreactivity in the locus coeruleus of the rat brain.

Authors:  M Smiałowska; B Legutko
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

7.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats.

Authors:  J T Clark; P S Kalra; W R Crowley; S P Kalra
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

8.  Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs.

Authors:  J M Lundberg; A Saria; A Franco-Cereceda; E Theodorsson-Norheim
Journal:  Acta Physiol Scand       Date:  1985-08

9.  Food deprivation and age modulate neuropeptide gene expression in the murine hypothalamus and adrenal gland.

Authors:  S C Chua; R L Leibel; J Hirsch
Journal:  Brain Res Mol Brain Res       Date:  1991-01

10.  Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.

Authors:  J M Lundberg; A Saria; A Franco-Cereceda; T Hökfelt; L Terenius; M Goldstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.